Skip to main content

Table 2 Standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) of cancers in patients with systemic lupus erythematosus (SLE), total and females

From: Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry—a historical cohort study

 

No. of observations

Expected value

SIR

95% CI

p-value

Total

38

35.1

1.08

0.74–1.43

0.649

Female

34

28.7

1.18

0.81–1.56

0.321